Literature DB >> 26010672

Global hypomethylation in myeloma is associated with poor prognosis.

Jonathan I Sive1, Andrew Feber2, Dean Smith3, John Quinn3, Stephan Beck2, Kwee Yong3.   

Abstract

Entities:  

Keywords:  epigenetics; methylation; multiple myeloma

Mesh：

Substances：

Year:  2015        PMID： 26010672     DOI： 10.1111/bjh.13506

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

Review 1.  Epigenetic regulatory mutations and epigenetic therapy for multiple myeloma.

Authors:  Daphné Dupéré-Richer; Jonathan D Licht
Journal:  Curr Opin Hematol       Date:  2017-07       Impact factor: 3.284

Review 2.  Epigenetic markers in melanoma.

Authors:  Weimin Guo; Ting Xu; Jonathan J Lee; George F Murphy; Christine G Lian
Journal:  Melanoma Manag       Date:  2015-11-24

Review 3.  Epigenetic Crosstalk between Malignant Plasma Cells and the Tumour Microenvironment in Multiple Myeloma.

Authors:  Alessandro Allegra; Marco Casciaro; Paola Barone; Caterina Musolino; Sebastiano Gangemi
Journal:  Cancers (Basel)       Date:  2022-05-24       Impact factor: 6.575

4.  The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains.

Authors:  Mohammad Alzrigat; Alba Atienza Párraga; Muntasir Mamun Majumder; Anqi Ma; Jian Jin; Anders Österborg; Hareth Nahi; Kenneth Nilsson; Caroline A Heckman; Fredrik Öberg; Antonia Kalushkova; Helena Jernberg-Wiklund
Journal:  Oncotarget       Date:  2017-10-20

Review 5.  Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma.

Authors:  Mark E Issa; Farnaz Sedigheh Takhsha; Wim Vanden Berghe; Muriel Cuendet; Chandra Sekhar Chirumamilla; Claudina Perez-Novo
Journal:  Clin Epigenetics       Date:  2017-02-10       Impact factor: 6.551

Review 6.  Role of microRNAs in Diagnosis, Prognosis and Management of Multiple Myeloma.

Authors:  Amro M Soliman; Teoh Seong Lin; Pasuk Mahakkanukrauh; Srijit Das
Journal:  Int J Mol Sci       Date:  2020-10-13       Impact factor: 5.923

7.  Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.

Authors:  Dörthe Holdhof; Pascal D Johann; Michael Spohn; Michael Bockmayr; Sepehr Safaei; Piyush Joshi; Julien Masliah-Planchon; Ben Ho; Mamy Andrianteranagna; Franck Bourdeaut; Annie Huang; Marcel Kool; Santhosh A Upadhyaya; Anne E Bendel; Daniela Indenbirken; William D Foulkes; Jonathan W Bush; David Creytens; Uwe Kordes; Michael C Frühwald; Martin Hasselblatt; Ulrich Schüller
Journal:  Acta Neuropathol       Date:  2020-12-17       Impact factor: 17.088

Review 8.  DNA Damage Response in Multiple Myeloma: The Role of the Tumor Microenvironment.

Authors:  Takayuki Saitoh; Tsukasa Oda
Journal:  Cancers (Basel)       Date:  2021-01-28       Impact factor: 6.639

Review 9.  One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies.

Authors:  Antonia Kalushkova; Patrick Nylund; Alba Atienza Párraga; Andreas Lennartsson; Helena Jernberg-Wiklund
Journal:  Epigenomes       Date:  2021-10-08

Review 10.  Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?

Authors:  Catharina Muylaert; Lien Ann Van Hemelrijck; Anke Maes; Kim De Veirman; Eline Menu; Karin Vanderkerken; Elke De Bruyne
Journal:  Front Oncol       Date:  2022-08-18       Impact factor: 5.738
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.